T-group (topology)
71.1.1 Lipoprotein localization factors LolAB
Ligands and drugs
847
Member domains
84
with ligand contacts (≤ 4 Å)
9.9% of members
71
with DrugDomain annotations
8.4% of members
42
with a DrugBank compound
5.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 71.1.1 belongs to X-group 71 Lipoprotein localization factors LolAB, which has 18 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03884 | PPY | Phenylpyruvic acid | 6 |
| DB00141 | NAG | N-Acetylglucosamine | 3 |
| DB00151 | CYS | Cysteine | 2 |
| DB02618 | NDS | Ethyl Dimethyl Ammonio Propane Sulfonate | 2 |
| DB00132 | LNL | alpha-Linolenic acid | 1 |
| DB02078 | PG5 | Triglyme | 1 |
| DB02210 | HEZ | Hexane-1,6-Diol | 1 |
| DB02637 | OAA | Oxaloacetate Ion | 1 |
| DB03193 | STE | Stearic acid | 1 |
| DB03756 | HXA | Doconexent | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 12 |
| ZNmetal | ZINC ION | 9 |
| CAmetal | CALCIUM ION | 6 |
| PPY | 3-PHENYLPYRUVIC ACID | 6 |
| MGmetal | MAGNESIUM ION | 3 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 3 |
| CYS | CYSTEINE | 2 |
| IG7 | [(2~{S})-3-[(2~{S})-3-azanyl-2-(hexadecanoylamino)-3-oxidanylidene-propyl]sulfanyl-2-hexadecanoyloxy-propyl] hexadecanoate | 2 |
| IOD | IODIDE ION | 2 |
| NAmetal | SODIUM ION | 2 |
| NDS | ETHYL DIMETHYL AMMONIO PROPANE SULFONATE | 2 |
| 4RF | Tripalmitoylglycerol | 1 |
| GLY | GLYCINE | 1 |
| HEZ | HEXANE-1,6-DIOL | 1 |
| HXA | DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID | 1 |
| IRmetal | IRIDIUM ION | 1 |
| LNL | ALPHA-LINOLENIC ACID | 1 |
| OAA | OXALOACETATE ION | 1 |
| P6G | HEXAETHYLENE GLYCOL | 1 |
| PG5 | 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE | 1 |